34 Kingdom, and West Africa. Infect Agent Cancer. 2009;4 (suppl_1):S2. https://doi. org/10.1186/1750-9378-4-S1-S2 29. Municipalities of South Africa. Free State municipalities [homepage on the Internet]. Cape Town: Yes Media CC; No date [cited 2021 Sep 09]. Available from: https://municipalities.co.za/provinces/view/2/free-state 30. Department of Health. Republic of South Africa. The national health promotion policy and strategy 2105–2019 [homepage on the Internet]. Pretoria: Department of Health; 2014 [cited 2021 Sep 09]. Available from: https://www.knowledgehub.org.za/system/les/elibdownlo ads/2019-07/Na tional%2520health%2520promotion%2520policy%2520and% 2520strate gy%25202015%2520-%25202019.pdf 31. Glynn M. Doctor and patient: General principles of history taking. In: Glynn M, Drake WM, editors. Hutchison’s clinical methods. An integrated approach to clinical practice. 23rd ed. London: Saunders Elsevier, 2012; p. 3–14. 32. Walker AR, Walker BF, Tsotetsi NG, Sebitso C, Siwedi D, Walker AJ. Case-control study of prostate cancer in Black patients in Soweto, South Africa. Br J Cancer. 1992;65(3):438–441. https://doi.org/10.1038/bjc.1992.89 33. Khan H. Determinants of prostate cancer: The Birmingham prostatic neoplasms association study [unpublished dissertation]. Birmingham: University of Birmingham; 2011. 34. Wazimap. Free State [homepage on the Internet]. Johannesburg: Media Monitoring Africa; 2016 [cited 2020 Mar 04]. Available from: https://wazimap. co.za/proles/province-FS-free-state 35. Kurian CJ, Leader AE, Thong MSY, Keith SW, Zeigler-Johnson CM. Examining relationships between age at diagnosis and health-related quality of life outcomes in prostate cancer survivors. BMC Public Health. 2018;18(1):1060. https://doi. org/10.1186/s12889-018-5976-6 36. American Cancer Society. Key statistics for prostate cancer [homepage on the Internet]. Kennesaw, GA; 2021 [last revised 2022 Jan 12; cited 2021 Dec 01]. Available from: https://www.cancer.org/cancer/prostatecancer/about/key- statistics.html 37. Ahmed RO, Sewram V, Oyesegun AR, Ayele B, Van Wyk A, Fernandez P. A comparison of clinicopathologic features of prostate cancer between Nigerian and South African Black men. Afr J Urol. 2022;28(1):6. https://doi.org/10.1186/ s12301-022-00273-y 38. Krstev S, Knutsson A. Occupational risk factors for prostate cancer: A meta-analysis. J Cancer Prev. 2019;24(2):91–111. https://doi.org/10.15430/ JCP.2019.24.2.91 39. Cheuck L. Prostate cancer diagnosis and staging [homepage on the Internet]. Medscape; 2021 [updated 2021 Apr 22; cited 2021 Nov 26]. Available from: https://emedicine.medscape.com/article/458011-overview 40. Shaw EK, Scott JG, Ferrante JM. The inuence of family ties on men’s prostate cancer screening, biopsy, and treatment decisions. Am J Mens Health. 2013;7(6):461–471. https://doi.org/10.1177/1557988313480226 41. Mofolo N, Betshu O, Kenna O, et al. Knowledge of prostate cancer among males attending a urology clinic, a South African study. Springerplus. 2015;4:67. https:// doi.org/10.1186/s40064-015-0824-y 42. Mbugua RG, Oluchina S, Karanja S. Prostate cancer awareness and screening among men in a rural community in Kenya: A cross-sectional study. Afr J Urol. 2021;27(7):1–10. https://doi.org/10.1186/s12301-020-00108-8 43. Coughlin SS, Vernon M, Klaassen Z, Tingen MS, Cortes JE. Knowledge of prostate cancer among African American men: A systematic review. Prostate. 2021;81(3):202–213. https://doi.org/10.1002/pros.24097 44. Lawson JS, Glenn WK. Evidence for a causal role by human papillomaviruses in prostate cancer – A systematic review. Infect Agent Cancer. 2020;15:41. https:// doi.org/10.1186/s13027-020-00305-8 45. Cheng I, Witte JS, Jacobsen SJ, et al. Prostatitis, sexually transmitted diseases, and prostate cancer: The California men’s health study. PLoS One. 2010;5(1):e8736. https://doi.org/10.1371/journal.pone.0008736 46. Clements MB, Vertosick EA, Guerrios-Rivera L, et al. Dening the impact of family history on detection of high-grade prostate cancer in a large multi-institutional cohort [published online ahead of print, 2021 Dec 31]. Eur Urol. 2021. https://doi. org/10.1016/j.eururo.2021.12.011 47. Ren ZJ, Cao DH, Zhang Q, et al. First-degree family history of breast cancer is associated with prostate cancer risk: A systematic review and meta-analysis. BMC Cancer. 2019;19(1):871. https://doi.org/10.1186/s12885-019-6055-9 48. Sherriff A, Da Costa N, Engelbrecht A, Li A, Prince N, Joubert G. Prostate cancer prole and risk stratication of patients treated at Universitas Annex Department of Oncology, Bloemfontein, Free State, during 2008 to 2010. S Afr Fam Pract. 2015;57(4):247–252. https://doi.org/10.1080/20786190.2014.993859 49. Salmon C, Song L, Muir K, et al. Marital status and prostate cancer incidence: A pooled analysis of 12 case-control studies from the PRACTICAL consortium. Eur J Epidemiol. 2021;36(9):913–925. https://doi.org/10.1007/s10654-021- 00781-1 50. Bennett CL, Ferreira MR, Davis TC, et al. Relation between literacy, race, and stage of presentation among lowincome patients with prostate cancer. J Clin Oncol. 1998;16(9):3101–3104. https://doi.org/10.1200/JCO.1998.16.9.3101 51. Vijayakumar V, Abern MR, Jagai JS, Kajdacsy-Balla A. Observational study of the association between air cadmium exposure and prostate cancer aggressiveness at diagnosis among a nationwide retrospective cohort of 230,540 patients in the United States. Int J Environ Res Public Health. 2021;18(16):8333. https://doi. org/10.3390/ijerph18168333 52. Jiménez-Mendoza E, Vázquez-Salas RA, BarrientosGutierrez T, et al. Smoking and prostate cancer: A life course analysis. BMC Cancer. 2018;18(1):160. https://doi. org/10.1186/s12885-018-4065-7 53. De Nunzio C, Andriole GL, Thompson IM Jr., Freedland SJ. Smoking and prostate cancer: A systematic review. Eur Urol Focus. 2015;1(1):28–38. https://doi. org/10.1016/j.euf.2014.10.002 54. Wilson KM, Mucci LA. Diet and lifestyle in prostate cancer. In: Dehm S, Tindall D, editors. Prostate cancer: Cellular and genetic mechanisms of disease development and progression. Advances in experimental medicine and biology. Volume 1210. 2nd ed. Switzerland: Springer Nature, 2019; p. 1–27. 55. Dhankhar R, Dahiya K, Ahlawat R, Dahiya P, Singh S, Gupta K. A review of the role portrayed by vitamin D in cancer. Cancer Ther Oncol Int J. 2018;11(2):555807. https://doi.org/10.19080/CTOIJ.2018.11.555807 56. Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014;21(3):319–329. https://doi.org/10.1016/j.chembiol.2013.12.016 57. John EM, Koo J, Schwartz GG. Sun exposure and prostate cancer risk: Evidence for a protective effect of early-life exposure. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1283–1286. https://doi.org/10.1158/1055-9965.EPI06-1053 58. Deb AA, Emmanuel O, Emara S, Abbas SA. Physical activity and prostate cancer: A systematic review. Urol Nephrol Open Access J. 2019;7(5):117–129. https://doi. org/10.15406/unoaj.2019.07.00258 59. Van Den Bergh RC, Albertsen PC, Bangma CH, et al. Timing of curative treatment for prostate cancer: A systematic review. Eur Urol. 2013;64(2):204–215. https:// doi.org/10.1016/j.eururo.2013.02.024 60. Xia L, Talwar R, Chelluri RR, Guzzo TJ, Lee DJ. Surgical delay and pathological outcomes for clinically localized high-risk prostate cancer. JAMA Netw Open. 2020;3(12):e2028320. https://doi.org/10.1001/jamanetworkopen.2020.28320 61. Vigneault E, Mbodji K, Aubin S, et al. Does delay from prostate cancer diagnosis to treatment with permanent seed implantation increase the risk of disease recurrence in men with clinically localized prostate cancer? Int J Radiat Oncol Biol Phys. 2017;99(2):E271–E272. https://doi.org/10.1016/j. ijrobp.2017.06.1251 UROLOGY, URO-ONCOLOGY AND SEXOLOGY UPDATE
RkJQdWJsaXNoZXIy NTIyOTQ=